Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.400.1%
QQQ
717.900.15%
BTC/USD
79726.281.9069%
DIA
532.520.29%
GLD
406.200.14%
TLT
82.190.02%

Viemed Healthcare Inc

VMDNASDAQ
Trade with Public
Trade with Public
$9.08
0.070.78%
At close: Sep 4, 5:00 PM EST
$9.08
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Viemed Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Viemed Healthcare (VMD).

Price Target Range — 1 Quarters

Analyst Consensus — 2 Analysts

1Buy
1Hold
Consensus RatingOutperform# Analysts2Avg. Consensus PT$13Upside to Avg. PT+37.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 24, 2026Barrington Research—InitiateOutperform$14
Aug 6, 2026Freedom BrokerIlya ZubkovDowngradeBuy→Hold$11

Analyst Ratings News

PRO
Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Viemed Healthcare, Lowers Price Target to $9

RBC Capital analyst Frank Morgan maintains Viemed Healthcare (NASDAQ:VMD) with a Outperform and lowers the price target from $13 to $9.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021

 
Benzinga Insights

PRO
RBC Capital Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $13

RBC Capital analyst Anton Hie initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $13.
Benzinga Newsdesk

PRO
Viemed Healthcare Q1 Sales $23.8M, Up 31% YoY

Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved